musselderived

Nanotechnology

Inhalation therapy uses mussel-derived nanoparticles to target lung cancer cells

Schematic representation of an inhalable mucoadhesive nanoanticancer drug based on mussel adhesion proteins (top) and therapeutic results in a lung cancer animal model (bottom). Credit: POSTECH Researchers from POSTECH and Kyungpook National University have developed a new inhalable treatment delivery system for lung cancer that leverages mucoadhesive protein nanoparticles inspired by the adhesive properties of marine shellfish. Lung cancer remains…